---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-24-022919"
form_type: "8-K"
ticker: "OPK"
cik: "0000944809"
company_name: "OPKO HEALTH, INC."
filed_at: "2024-07-17T23:59:59+00:00"
generated_at: "2026-05-31T20:22:32.417303+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# OPKO Health issues $250M senior secured notes due 2044, secured by NGENLA profit share payments from Pfizer

## Summary
- Notes bear interest at 3-month SOFR + 7.5% (floor 4%); interest-only for first 4 years.
- No principal payments required before July 2028; principal repaid from NGENLA profit share payments.
- Proceeds provide non-dilutive capital for R&D, including multispecific antibody programs, and potential share/convertible note repurchases.
- Exit fee of 3% on repayment; make-whole provision up to 200% of principal if prepaid after year 5.
- OPKO retains full benefit of up to $100M in remaining milestone payments from Pfizer for NGENLA.

## SEC filing metadata
- accession: 0001437749-24-022919
- form_type: 8-K
- ticker: OPK
- cik: 0000944809
- company_name: OPKO HEALTH, INC.
- filed_at: 2024-07-17T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 2.03, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/944809/000143774924022919/0001437749-24-022919-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/944809/000143774924022919/opk20240717_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-24-022919
- JSON: https://secwatch.observer/filing/0001437749-24-022919.json
- Plain text: https://secwatch.observer/filing/0001437749-24-022919.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.